Get started
Live feed
PRReleasevia Quantisnow
Molecular Partners AG logo

Molecular Partners and Orano Med Announce First Patients Dosed in Phase 1/2a Trial of DLL3 Radio-DARPin MP0712

ByQuantisnow··Wall Street's wire, on your screen.
Stocks in this Quantisnow insight

Historical context for MOLN

Across the 21 sessions after earlier MOLN headlines, the stock closed higher 12 times and lower 8 times, with a median move of 3.4% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.

MOLN close-to-close change in the session after earlier headlines
SessionEarlier headlineMOLNSPY
Jun 1, 2026Molecular Partners Holds Presentations at ASCO and SNMMI 2026 on DLL3-Targeting Radio-DARPin MP0712, Now Dosing Patients in Phase 1-6.0%+0.3%
May 27, 2026Molecular Partners to Present at TD Cowen's 7th Annual Oncology Innovation Summit-0.2%-0.0%
May 13, 2026Molecular Partners Reports Financial Results and Highlights for Q1 2026, with Clinical Studies Initiated on MP0712 and MP0317-1.0%+0.6%
May 4, 2026Molecular Partners to hold oral presentations on DLL3-targeting Radio-DARPin candidate MP0712 at multiple upcoming scientific conferences+3.9%-0.4%
May 1, 2026Molecular Partners publishes Phase 1 MP0317 data in Nature Cancer demonstrating tumor-localized CD40 activation and tumor microenvironment remodeling+0.2%+0.3%
Apr 20, 2026Molecular Partners presents three posters at AACR 2026, with new preclinical data for first Switch-DARPin T cell engager MP0632 and DLL3 Radio-DARPin MP0712+4.9%-0.2%
Quantisnow market dataNASDAQ
Molecular Partners AG logo
MOLN
Molecular Partners AG
Market cap
30-day
Sector
Health Care
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Listed since
2021
Get push alerts for MOLN

Follow MOLN and get a push notification the moment its next story breaks.

Full MOLN profile on Quantisnow

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track MOLN (Molecular Partners AG) and more on Quantisnow.